Beijing, China

Haoshan Wang


Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haoshan Wang: Innovator in Pharmaceutical Chemistry

Introduction

Haoshan Wang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of medicine and the chemical industry. His work focuses on developing compounds that have the potential to improve health outcomes.

Latest Patents

Haoshan Wang holds a patent for a compound known as 4,4-diphenylpiperidine or its pharmaceutically acceptable salts. This invention is particularly relevant in the pharmaceutical sector, as it relates to a compound that exhibits significant activity in blocking N-type calcium channels. The pharmaceutical composition derived from this compound has shown promise in effectively relieving pain and addressing various medical conditions, including stroke, cerebral ischemia, and alcohol addiction. The patent highlights the compound's good pharmacokinetic properties, making it a potential new medicament for several health issues.

Career Highlights

Wang is affiliated with the Academy of Military Medical Sciences, where he conducts research and development in pharmaceutical chemistry. His work has garnered attention for its innovative approach to pain management and treatment of addictive disorders.

Collaborations

Haoshan Wang collaborates with notable colleagues, including Cheng Zhang and Guoxing Dong. Their combined expertise contributes to advancing research in the pharmaceutical field.

Conclusion

Haoshan Wang's contributions to pharmaceutical chemistry, particularly through his patented compound, demonstrate his commitment to innovation in medicine. His work has the potential to significantly impact pain management and treatment strategies in various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…